Zydus Lifesciences receives 6 observations from USFDA for Gujarat API unit – Times of India
Zydus Lifesciences on Saturday said it received six observations from the US Food and Drug Administration (USFDA) following a surveillance inspection of its active pharmaceutical ingredient (API) manufacturing facility in…